您的位置: 首页 > 农业专利 > 详情页

Sustained release pharmaceutical oral solid dosage form of dronedarone or one of its pharmaceutically acceptable salts
专利权人:
发明人:
申请号:
EP11305874.7
公开号:
EP2543362A1
申请日:
2011.07.07
申请国别(地区):
EP
年份:
2013
代理人:
摘要:
The instant invention relates to a sustained release pharmaceutical oral solid dosage form comprising a therapeutically effective amount of dronedarone or pharmaceutically acceptable salts thereof adapted to release over a predetermined time period according to a profile of dissolution characterized in that an amount comprised between 55 and 85% of dronedarone or pharmaceutically acceptable salts thereof is liberated at 240 minutes.Preparation and application in therapeutics.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充